Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis.
about
Antibiotic treatment for Clostridium difficile -associated diarrhea in adultsAntibiotic treatment for Clostridium difficile-associated diarrhea in adultsRifalazil treats and prevents relapse of clostridium difficile-associated diarrhea in hamstersClostridium difficile: its disease and toxinsBench-to-bedside review: Clostridium difficile colitisEfficacy and Safety of Metronidazole Monotherapy versus Vancomycin Monotherapy or Combination Therapy in Patients with Clostridium difficile Infection: A Systematic Review and Meta-AnalysisWSES guidelines for management of Clostridium difficile infection in surgical patientsClostridium difficile Infection in Children: Current State and Unanswered QuestionsRecurrent Clostridium difficile infections: the importance of the intestinal microbiotaTrends in Clostridium difficile Disease: Epidemiology and InterventionSaccharomyces boulardii'. A Review of an Innovative Biotherapeutic AgentThe challenges posed by reemerging Clostridium difficile infection.Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults.Antibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation.Antibiotic Regimen after a Total Abdominal Colectomy with Ileostomy for Fulminant Clostridium difficile Colitis: A Multi-Institutional Study.Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials.Fecal lactoferrin, interleukin-1beta, and interleukin-8 are elevated in patients with severe Clostridium difficile colitisAntimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997.Liver abscess caused by Clostridium difficile.Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole.Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide.In vitro and in vivo evaluation of tiacumicins B and C against Clostridium difficileFaecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection.The potential value of Clostridium difficile vaccine: an economic computer simulation model.Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting.Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin.Risk Factors for Treatment Failure and Recurrence after Metronidazole Treatment for Clostridium difficile-associated Diarrhea.Clostridium difficile colitis: a review.Clostridium difficile infection in patients with neutropenia.Risk factors for acquisition of Clostridium difficile-associated diarrhea among outpatients at a cancer hospital.Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis.Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile.A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.Treatment of Clostridium difficile-associated diarrhea.An agent-based simulation model for Clostridium difficile infection controlEfficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infectionsA review of the economics of treating Clostridium difficile infection.Clostridium difficile Infection and Inflammatory Bowel Disease: A Review.The insect peptide coprisin prevents Clostridium difficile-mediated acute inflammation and mucosal damage through selective antimicrobial activity.Clostridium difficile infection: current, forgotten and emerging treatment options.
P2860
Q24234378-48C0F47F-63DB-4C5A-B18D-88B798DB79A7Q24244302-B79DD13E-B939-4954-B4C0-B9287C07F315Q24563857-E6C8EDD4-CC69-4DDF-9D7E-862AC8B961A5Q24617347-4C5739F0-B9CC-4AB7-97E4-2EB13B408C43Q24644191-6FDF25BB-9220-4BD9-9064-8ACE233F079BQ26786662-3F8E464F-7ECE-46CB-AE33-5CA2BD97142BQ26795429-D767D151-DD8F-41BB-969B-40B142D9E7CAQ27016320-0BC55BC6-5595-42BE-83AB-00DE0F1E552EQ27023219-76DF58A0-7261-4CAA-ABDF-5DDB83298189Q28655729-13299D38-ACD6-4458-AFD6-D26567353DF4Q29013282-70441595-4DC5-466E-9461-365DF6EC0418Q30229530-935C1394-524F-4CC8-BC98-E23A900440AFQ30235446-31E51A00-31D1-417B-BF2A-D62E93FFBEFDQ30238945-C327A0DF-1D4A-485A-A7A9-2144112FDEE2Q30279196-03F20574-9B7D-4961-9BFA-0F6040B974F0Q30425705-948DFE90-8D04-40BF-86CD-7187942F3FBBQ30452864-33FA5551-BC98-4DC2-A4DF-22996DB4C510Q30804635-5B93014E-667B-431D-B6C6-958AC001D9B3Q32107823-E78AD567-62AD-4B4A-BA1D-5109A5CC97AFQ33214954-3B69DCF3-6627-46DA-B82B-B956704B0DF1Q33276804-7D70F6F2-C771-46AB-837A-71EB0207E217Q33743827-E0EF4B8B-FD5C-48FA-B631-280C7B37FF43Q33782277-FB960D03-BCE0-4CFD-851D-DBD497BF1679Q34012314-97C3ED2F-7DF5-4C06-8106-C5376755F864Q34072892-461B291E-9CCA-4A54-A2EA-501A34C9D6E1Q34108924-2508CCE8-094B-4EDA-9541-DDC41BDBD815Q34206660-D04F8538-1F4C-400D-87C6-0D09127CC31CQ34260389-92AC5BB8-B597-4EC5-B048-254F03A65E95Q34340965-E079F3ED-CEAC-4643-AD90-0C216155C26BQ34450149-E54DAACF-EDBD-4C19-AE4D-A61A86658DA9Q34528243-D613DB1F-C651-4DFD-BDD1-316FB0CAEF41Q34530913-D7DD67EA-0FF6-4678-B9AC-2104D410B217Q34643123-1258D6E2-A31D-4D56-B50D-20AA169A28D3Q34979678-C80A88A8-F888-405D-AD7F-A863197AFE4CQ35031203-D5726DE6-4872-493D-9B0C-33FE9050553FQ35164536-8BA2E05D-3CA5-45F7-84D1-214339DAEE04Q35164905-6FD1696D-02B1-415A-8ED0-B6E99325D9DEQ35208564-7BF4113A-8A6E-4D19-A4B7-4A3217C9B0E1Q35270823-6C3227E5-DEC7-4330-9A3A-BB11C56CF62CQ35372397-7A7A66FD-BDEB-483F-A439-9EA72C461720
P2860
Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis.
description
1983 nî lūn-bûn
@nan
1983 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
name
Prospective randomised trial o ...... ociated diarrhoea and colitis.
@ast
Prospective randomised trial o ...... ociated diarrhoea and colitis.
@en
Prospective randomised trial o ...... ociated diarrhoea and colitis.
@nl
type
label
Prospective randomised trial o ...... ociated diarrhoea and colitis.
@ast
Prospective randomised trial o ...... ociated diarrhoea and colitis.
@en
Prospective randomised trial o ...... ociated diarrhoea and colitis.
@nl
prefLabel
Prospective randomised trial o ...... ociated diarrhoea and colitis.
@ast
Prospective randomised trial o ...... ociated diarrhoea and colitis.
@en
Prospective randomised trial o ...... ociated diarrhoea and colitis.
@nl
P2093
P1433
P1476
Prospective randomised trial o ...... ociated diarrhoea and colitis.
@en
P2093
D G Teasley
D N Gerding
L R Peterson
M J Schwartz
R L Gebhard
P304
P356
10.1016/S0140-6736(83)91036-X
P407
P577
1983-11-01T00:00:00Z